TLRY Tilray

Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs

Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs

Good Supply Expands Product Lineup with 1.5g and 2g Vapes

TORONTO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, has announced the introduction of Good Supply's latest product innovation: Monsters 1,000mg THC Resin Vapes. Building on the success of their popular , the Good Supply Monsters collection is now expanding into the vape category with two strain x strain pairings: Grape Daddy Kush and Super Lemon Guy.

Monsters Vapes are designed to hit full spectrum heights. Each 1.5g cart is packed with 1000mg of THC, offering a potent and tasty vaping experience with strain-specific full spectrum BHO resin and a second helping of cannabis terpenes for two hard-hitting entourage effects.



Good Supply Monsters Vape Options:

  • Grape Daddy Kush (Indica): A ghastly indica experience that merges Sweet Berry Kush BHO x Grand Daddy Purps cannabis terpenes, delivering sweet berry and pungent grape flavours, perfect when winding down in the evening.
  • Super Lemon Guy (Sativa): A spooky sativa blend of Jean Guy BHO x Super Lemon Haze cannabis terpenes, with lemon, citrus, and earthy notes, ideal when starting the day with a boost or when you are on energetic adventures with friends.

Key Monsters Vape Features:

  • 1,000mg THC per 1.5g cart.
  • Brings together 2x entourage effects with full spectrum BHO Resin and cannabis terpenes.
  • Custom-designed heating coil, crafted with a specialized alloy for faster, harder hits
  • Wider Mouthpiece: The extra-wide mouthpiece ensures better airflow and is less likely to clog, enhancing the overall vaping experience.

"We’re beyond excited to expand our Monsters line into the vape category," said Michelle Morin, Senior Brand Manager, Good Supply. "Our original Monsters infused pre-rolls have set a high standard for unconventionally impactful products, and with Monsters Vapes, we’re taking the vaping experience to a whole new level. Consumers and fans can expect the same dedication to innovation and quality in our new Monsters vape products for double the entourage effects and flavour."



This introduction of Monsters Vapes represents a strategic expansion into a rapidly growing full-spectrum segment of the cannabis market. This launch underscores Good Supply's dedication to innovation and its ability to meet consumer demand with better quality, hard-hitting products.



In addition to the Monsters Vapes, Good Supply continues to offer an extensive vape product line tailored to different consumer preferences. The newest offerings include 2g 510 Vapes containing up to 50% THC, 15% CBG, and 15% CBD, 1.2g ‘Twisted’ All-In-One Vapes featuring 3-in-1 flavours, and the popular 1g 510 Cartridge vapes. Each product is formulated using double distilled and double filtered THC distillate, complemented by natural flavouring ingredients for a fruity and flavourful experience. The cartridges are designed to be compatible with all 510 standard rechargeable batteries and feature mouthpieces made from hemp material, aligning with Good Supply's commitment to reducing plastic waste.





Grab 1.5g Monsters Vapes in Grape Daddy Kush and Super Lemon Guy at select retailers and locations nationwide. For more information about Good Supply’s latest products and innovations, follow @goodsupplycannabis.

About Good Supply

Good Supply is one of Canada's leading cannabis brands and has been recognized as #1 in flower, and best-selling pre-rolls, vapes, and concentrates, and has become a favourite among consumers and budtenders. At Good Supply, good is the new great. Rooted in classic strains that punch above their weight, Good Supply delivers consistent, hard-hitting quality at affordable prices. Explore classic cannabis strains, innovative formats, and new flavours – we’re always up for a good time.

To learn more about Good Supply and its latest product launches, visit their .

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit and follow @Tilray.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations.  Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws. 

For further information, please contact

Media:

Investors:

Photos accompanying this announcement are available at



EN
20/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...

 PRESS RELEASE

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...

 PRESS RELEASE

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...

 PRESS RELEASE

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement wi...

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with , a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products...

 PRESS RELEASE

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in De...

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen Pharmamarkt DENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass , ihr europäischer Pharmahändler, zu einem der ernannt wurde. Hierbei handelt es sich um eine der renommiertesten und unabhängigsten Auszeichnungen für Innovation bei kleinen und mittleren Unternehmen des La...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch